StockData

Actinium Pharmaceuticals vs Soligenix

ATNM and SNGX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ATNM and SNGX compare

Actinium Pharmaceuticals is the larger company, worth 7.0 times as much as Soligenix ($42.4M against $6.1M).

Actinium Pharmaceuticals scores higher on the StockData Score (10 against 6 for Soligenix), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricATNMSNGX
Size and price
Market cap$42.4M$6.1M
Share price$1.35$0.281
Change, 1 year6.3%−79.5%
Change, 5 years−81.5%−99.9%
Beta (5Y)1.382.38
Employees2514
StockData Score
Total score10 (better)6
Valuation score4 (better)1
Growth score00
Performance score1 (better)0
Health score55
Dividend score00
Valuation
P/E3.8×–
P/B1.4×0.9× (better)
EV/EBITDA0.6×–
Fair value$7.16–
Margin of safety81.1%–
Profitability
Return on equity45.9% (better)−242%
Financial health
Debt / equity0.000.00
Current ratio4.08 (better)2.77
Altman Z-score−9.28 (better)−35.09
Piotroski F-score23 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions16.8%4.3%
Held by insiders5.9%0.69%
Short interest, % of float2.0%0.31%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.